Table 1.
Clinical features of LGG patients from TCGA
| Clinical features | Total (477) | % | |
|---|---|---|---|
| Age | Age ≤ 45 | 287 | 60.17% |
| Age > 45 | 190 | 39.83% | |
| Gender | Female | 216 | 45.28% |
| Male | 261 | 54.72% | |
| Grade | WHO II | 231 | 48.43% |
| WHO III | 246 | 51.57% | |
| 1p/19q | Non-codel | 321 | 67.30% |
| Codel | 156 | 32.70% | |
| IDH | Mutant | 389 | 81.55% |
| Wildtype | 85 | 17.82% | |
| Unknow | 3 | 0.63% | |
| MGMT | Unmethylated | 82 | 17.19% |
| Methylated | 395 | 82.81% |